BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8406591)

  • 1. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae.
    Rainard P
    Immunology; 1993 Aug; 79(4):648-52. PubMed ID: 8406591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
    Rainard P; Sarradin P; Poutrel B
    Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.
    Rainard P; Boulard C
    Infect Immun; 1992 Nov; 60(11):4801-8. PubMed ID: 1398991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposition of complement components on Streptococcus agalactiae in bovine milk in the absence of inflammation.
    Rainard P; Poutrel B
    Infect Immun; 1995 Sep; 63(9):3422-7. PubMed ID: 7642272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ; Kasper DL
    J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of bovine fibronectin to mastitis-causing Streptococcus agalactiae induces adherence to solid substrate but not phagocytosis by polymorphonuclear cells.
    Rainard P
    Microb Pathog; 1993 Mar; 14(3):239-48. PubMed ID: 8321125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.
    Carlsson F; Sandin C; Lindahl G
    Mol Microbiol; 2005 Apr; 56(1):28-39. PubMed ID: 15773976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
    Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR
    J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
    Zaragoza O; Casadevall A
    Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
    Pier GB; Grout M; Desjardins D
    J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ingestion and killing of Streptococcus agalactiae by bovine granulocytes in the presence of natural opsonins.
    Rainard P; Lautrou Y; Poutrel B
    Vet Microbiol; 1988 Sep; 18(1):41-50. PubMed ID: 3055659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of C3 in mediating binding and ingestion of group B streptococcus serotype III by murine macrophages.
    Noel GJ; Katz SL; Edelson PJ
    Pediatr Res; 1991 Jul; 30(1):118-23. PubMed ID: 1891276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-independent killing of gram-negative bacteria via the classical pathway.
    Clas F; Loos M
    Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis.
    Ben Nasr A; Klimpel GR
    J Leukoc Biol; 2008 Jul; 84(1):77-85. PubMed ID: 18430786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.